We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
-4.82%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$77.9M
AUM Growth
+$11.2M
Cap. Flow
+$16.2M
Cap. Flow %
20.77%
Top 10 Hldgs %
91.07%
Holding
36
New
8
Increased
13
Reduced
5
Closed
6

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$3.12M
2
ABT icon
Abbott
ABT
+$2.97M
3
EHAB
Enhabit
EHAB
+$787K
4
ODP
ODP
ODP
+$481K
5
SEAT icon
Vivid Seats
SEAT
+$295K

Top Sells

Rank Stock Value
1
ZVRA icon
Zevra Therapeutics
ZVRA
+$250K
2
NFLX icon
Netflix
NFLX
+$229K
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$163K
4
COMS
COMSovereign Holding Corp. Common Stock
COMS
+$38.5K
5
ADBE icon
Adobe
ADBE
+$11K

Sector Composition

Rank Sector Weight
1 Healthcare 52.5%
2 Industrials 16.5%
3 Communication Services 9.34%
4 Financials 4.95%
5 Technology 1.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
26
Apple
AAPL
$4.9T
$208K 0.27%
1,217
+27
+2% +$4.95K
ORCL icon
27
Oracle
ORCL
$364B
$206K 0.26%
1,944
+23
+1% +$2.66K
ADT icon
28
ADT
ADT
$5.13B
$180K 0.23%
+30,000
New +$187K
JETS icon
29
US Global Jets ETF
JETS
$865M
$170K 0.22%
+10,000
New +$197K
GENI icon
30
Genius Sports
GENI
$1.68B
$160K 0.21%
+30,000
New +$199K
BMRN icon
31
PUT
BioMarin Pharmaceuticals
BMRN
$11.5B
– –
-25,000
Closed -$2.17M
HBI
32
CALL
DELISTED
Hanesbrands
HBI
– –
-50,000
Closed -$227K
NFLX icon
33
Netflix
NFLX
$290B
– –
-5,190
Closed -$229K
ZVRA icon
34
CALL
Zevra Therapeutics
ZVRA
$755M
– –
-131,700
Closed -$672K
ZVRA icon
35
Zevra Therapeutics
ZVRA
$755M
– –
-49,100
Closed -$250K
COMS
36
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
– –
-22,500
Closed -$38.5K
1
2

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, DSC Advisors held 36 positions worth $77.9M, up 17% from $66.7M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

DSC Advisors deployed $16.2M of net new capital in Q3 2023, opening 8 new positions and adding to 13 existing holdings. Its largest new stake was ODP: 10,000 shares worth $462K.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 54% a quarter earlier, followed by Industrials and Communication Services.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $163K trimmed.

  • DSC Advisors's largest Q3 2023 buy was ODP: 10,000 shares worth $462K.
  • DSC Advisors added most to CVS Health in Q3 2023, an estimated $3.12M increase.
  • DSC Advisors's biggest Q3 2023 reduction was Teva Pharmaceuticals, cutting an estimated $163K.
  • DSC Advisors fully exited Zevra Therapeutics in Q3 2023, selling an estimated $250K.
  • DSC Advisors's ten largest holdings make up 91% of its $77.9M portfolio in Q3 2023.
  • DSC Advisors opened 8 new positions and closed 6 in Q3 2023.
  • DSC Advisors's portfolio value rose 17% quarter-over-quarter to $77.9M.

Based on DSC Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.